Butyrate mitigates metabolic dysfunctions via the ERα-AMPK pathway in muscle in OVX mice with diet-induced obesity. Fu Q, Li T, Zhang C, Ma X, Meng L, Liu L, Shao K, Wu G, Zhu X, & Zhao X. Cell Communication and Signaling. 5/4/2023.

Butyrate mitigates metabolic dysfunctions via the ERα-AMPK pathway in muscle in OVX mice with diet-induced obesity Fu Q, Li T, Zhang C, Ma X, Meng L, Liu L, Shao K, Wu G, Zhu X, & Zhao X. Cell Communication and Signaling 5/4/2023

Adipocyte YTH N(6)-methyladenosine RNA-binding protein 1 protects against obesity by promoting white adipose tissue beiging in male mice. Yan S, Zhou X, Wu C, Gao Y, Qian Y, Hou J, Xie R, Han B, Chen Z, Wei S & Gao X. Nature Communications. 3/13/2023.

Adipocyte YTH N(6)-methyladenosine RNA-binding protein 1 protects against obesity by promoting white adipose tissue beiging in male mice Yan S, Zhou X, Wu C, Gao Y, Qian Y, Hou J, Xie R, Han B, Chen Z, Wei S & Gao X. Nature Communications 3/13/2023

Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolism. Liu K, Liu S, Wu C, Wang Y, Zhang Y, Yu J, Liu S, Li X, Qi X, Su S, Qi X, Zhou L, & Li L. International Immunopharmacology. 3/11/2023.

Rhynchophylline relieves nonalcoholic fatty liver disease by activating lipase and increasing energy metabolism Liu K, Liu S, Wu C, Wang Y, Zhang Y, Yu J, Liu S, Li X, Qi X, Su S, Qi X, Zhou L, & Li L. International Immunopharmacology 3/11/2023

The combined effect of metformin and mirabegron on diet-induced obesity. Zhao X-Y, Liu Y, Zhang X, Zhao B-C, Burley G, Yang Z-C, Luo Y, Li A-Q, Zhang R-X, Liu Z-Y, Shi Y-C, & Wang Q-P. MedComm. 2/14/2023.

The combined effect of metformin and mirabegron on diet-induced obesity Zhao X-Y, Liu Y, Zhang X, Zhao B-C, Burley G, Yang Z-C, Luo Y, Li A-Q, Zhang R-X, Liu Z-Y, Shi Y-C, & Wang Q-P. MedComm 2/14/2023

The clock-modulatory activity of Nobiletin suppresses adipogenesis via Wnt signaling. Xiong X, Kiperman T, Li W, Dhawan S, Lee J, Vijay Y, & Ma K. bioRxiv. 2/8/2023.

The clock-modulatory activity of Nobiletin suppresses adipogenesis via Wnt signaling Xiong X, Kiperman T, Li W, Dhawan S, Lee J, Vijay Y, & Ma K. bioRxiv 2/8/2023

High-fat/high-sucrose diet worsens metabolic outcomes and widespread hypersensitivity following early-life stress exposure in female mice. Frick JM, Eller OC, Foright RM, Levasseur BM, Yang X, Wang R, Winter MK, O’Neil MF, Morris EM, Thyfault JP, & Christianson JA. American Physiological Society. 1/24/2023.

High-fat/high-sucrose diet worsens metabolic outcomes and widespread hypersensitivity following early-life stress exposure in female mice Frick JM, Eller OC, Foright RM, Levasseur BM, Yang X, Wang R, Winter MK, O’Neil MF, Morris EM, Thyfault JP, & Christianson JA. American Physiological Society 1/24/2023

Liver Fibroblast Growth Factor 21 (FGF21) is Required for the Full Anorectic Effect of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide in Male Mice fed High Carbohydrate Diets. Le TDV, Fathi P, Watters AB, Ellis BJ, Bozadjieva-Kramer N, Perez MB, Sullivan AI, Rose JP, Baggio LL, Koehler J, Brown JL, Bales MB, Nwaba KG, Campbell JE, Drucker DJ, Potthoff MJ, Seeley RJ, & Ayala JE. BioRxiv. 1/4/2023.

Liver Fibroblast Growth Factor 21 (FGF21) is Required for the Full Anorectic Effect of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide in Male Mice fed High Carbohydrate Diets Le TDV, Fathi P, Watters AB, Ellis BJ, Bozadjieva-Kramer N, Perez MB, Sullivan AI, Rose JP, Baggio LL, Koehler J, Brown JL, Bales MB, Nwaba KG, Campbell JE,…

Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-induced Chronic Kidney Disease. Udi S, Hinden L, Earley B, Drori A, Reuveni N, Cinar RHR, Nemirovski A, & Tam J. Unknown. 12/28/2022.

Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-induced Chronic Kidney Disease Udi S, Hinden L, Earley B, Drori A, Reuveni N, Cinar RHR, Nemirovski A, & Tam J. Unknown 12/28/2022